Current Fellows
Former Fellows
Fellow | Thesis | Thesis Mentor | Current Institution |
Rahul Krishnan, MD 2021-2024 | Spatial multi-omics characterize the transition from borderline ovarian tumors to low-grade serous ovarian cancer | Ernst Lengyel, MD, PhD | Northwestern Memorial Hospital |
Sarah Ackroyd, MD 2020-2023 | Pembrolizumab and Lenvatinib versus Carboplatin and Paclitaxel as first line therapy for advanced or recurrent endometrial cancer: A Markov Analysis | Elbert Huang, MD and Nita Lee, MD, MPH | The University of Chicago |
Melissa Javellana, MD 2019-2022 | Neoadjuvant Chemotherapy Induces Genomic and Transcriptomic Changes in Ovarian Cancer | Ernst Lengyel, MD, PhD | The University of Kansas Medical Center |
Raanan Alter, MD 2018-2021 | Strategies to reverse immunosuppression in PTEN deficient gynecologic cancers by tumor cell intrinsic STING/IFN-B signaling | Akash Patnaik, MD | Northwestern Medicine |
Isabel Lazo, MD 2017-2020 | Profiling metabolite changes in the ovarian cancer secretome and its impact on alterations in human primary mesothelial cells | Ernst Lengyel, MD, PhD Hilary Kenny, PhD | Stanford Medicine |
Claire Hoppenot, MD, PhD 2016-2019 | Genomics and proteomics of long-term survivors of advanced-stage high-grade serous ovarian cancer | Ernst Lengyel, MD, PhD | Baylor College of Medicine |
Jerlinda Ross, MD, MS 2015-2018 | Endometrial Cancer Survivor’s Access to Recommended Self-Care Resources for Obesity in a High-Poverty Urban Community | Stacy Lindau, MD, MAPP Nita Lee, MD, MPH | Medical University of South Carolina |
Josephine Kim, MD 2014-2017 | Combination simvastatin/metformin for endometrial cancer treatment and prevention | Gustavo Rodriguez, MD | University of Chicago |
Terri Febbraro, MD 2013-2016 | Inhibition of BI integrin impedes ovarian cancer metastasis via redirection in lactate production resulting in decreased proliferation, angiogenesis and cancer stem cell population | Ernst Lengyel, MD, PhD | MaineHealth Medical Center |
Andrea Jewel, MD 2012-2015 | MicroRNA 206 is associated with longer overall survival and platinum sensitivity in serous epithelial ovarian cancer | Ernst Lengyel, MD, PhD | The University of Kansas Health System |
Andras Ladyani, MD 2011-2014 | Expression of fatty acid transporters in ovarian cancer | Ernst Lengyel, MD, PhD | Rush University Medical Center |
Jessica Hunn, MD 2011-2014 | Developing an effective pharmacologic approach for the chemoprevention of ovarian and uterine cancer | Gustavo Rodriguez, MD | Valley Women’s Health |